2018
DOI: 10.1016/j.aquaculture.2018.05.051
|View full text |Cite
|
Sign up to set email alerts
|

Symbiont-derived sphingolipids regulate inflammatory responses in rainbow trout (Oncorhynchus mykiss)

Abstract: Farmed fish live in association with diverse bacterial communities that produce wide arrays of metabolites. In rainbow trout, the skin and the gills are colonized by Flectobacillus major, a bacterium known to produce sphingolipids (SLs). The goal of this study is to evaluate the ability of F. major SLs to regulate rainbow trout inflammatory responses. F. major SLs were delivered by themselves or in combination with Freund’s Complete Adjuvant (FCA), an oil-based adjuvant known to cause severe abdominal inflamma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…However, since antibiotics lead to bacterial resistance generation, their use is discouraged nowadays, and several countries with major fish-producing facilities have banned their inclusion in biosecurity plans. Therefore, to improve fish robustness in aquaculture settings, several strategies based on the use of alternative sources like phytogenics [ 210 ], live microbes [ 211 , 212 ], their metabolic products like short-chain fatty acids (SCFA) [ 213 ] and sphingolipids [ 214 ], or structural components like peptidoglycan [ 215 ] or B-glucan [ 216 ] have been extensively tested in the last century as possible therapeutics for fish. Nevertheless, despite the entire group being potentially effective, all the previous strategies lack any specificity against a particular fish disease.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…However, since antibiotics lead to bacterial resistance generation, their use is discouraged nowadays, and several countries with major fish-producing facilities have banned their inclusion in biosecurity plans. Therefore, to improve fish robustness in aquaculture settings, several strategies based on the use of alternative sources like phytogenics [ 210 ], live microbes [ 211 , 212 ], their metabolic products like short-chain fatty acids (SCFA) [ 213 ] and sphingolipids [ 214 ], or structural components like peptidoglycan [ 215 ] or B-glucan [ 216 ] have been extensively tested in the last century as possible therapeutics for fish. Nevertheless, despite the entire group being potentially effective, all the previous strategies lack any specificity against a particular fish disease.…”
Section: Future Perspectivesmentioning
confidence: 99%